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The Immrllate reproducibility efsustained ventricular taehv(ar-
din inducion was ead noted prlapeclisely during 106 studies
performed in 53
portents
with clinical sustained mosomorphic
nentrieniar
Programmed
eleeirltal stimulation was
performed twice, using the same protocol during 53 drug-free
studies and 53 subsequent studies an antiardglhmie lherapy,
Sustained monnmarphic
ventricular
rachycardia was repro-
duced to 104 (98%) of the 106 studies . There was no sigsdiiomt
difference In the incidence of reproducible tachycardia in the
drug-free state compared with that observed during treatment
with differeat classes orantitrhythmir drugs
. An increase in the
number ofentrwstimuli was require to reinitiate the cachycardia
In 9 (11%) of 03 srwdirs in which single or double estrastimuli
Programmed cardiac stimulation is widely used in the man-
agement of sustained ventricular tachycardia . Several stud-
ies (1-3) demonstrating she value of programmed cardiac
stimulation in predicting the long-term efficacy of antiar-
rhythmic drug therapy have used the intravenaus as well as
oral route of drug administration. The immediate reproduc-
ibility of cachycardia induction by programmed stimulation
is critieat
. especially in laboratories using acute intravenous
drug testing immediately otter baseline programmed stimu-
lation to predict the fissure efficacy of oral drug therapy
(4-6) . Furthermore . because an antiarrhythmic drug may he
considered partially effective and therefore clinically useful
if it modifies ventricular tachycardia induction or coos the
induced cachycardia rate without completely suppressing it
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were initially required
Iv induce the (achycardia . i 3913790) of
104 studies with
reproducible tachycardla Induction, the two
tacbycardias sipnincanlly differed In dedroeardlonno a (ECG)
ranfiguratiao and cycle hagth
.
These observations saggeoi dud the overall
reproducibility
d
ventricular mchyeardla induction is sullieieedy high to pemide a
reliable marker for eaaluating the efscncy of therapeadr interveo-
lions
. However, speeltie lachycardia charaMmistics such as cycle
length and ECG
configuration
are more varlahit earn within the
same study and m y be less usefd in assessing the effits of
subsequent interventions .
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17-9) . the reproducibility of induction modes and induced
tachycardia characteristics such as cycle length before and
after changes in drug therapy are clinically important- To
date . few studies (10.11) have critically addressed the issue
of immediate
reproducibility
of cachycardia induction and
have done so only in the drug-free state .
The parpose trf this prospective study was to: l) de[er-
mine the overall immediate reproducibility of sustained
mmsomorphic ventricular tachycardia induced by pro-
grammed cardiac stimulation in patients presenting with
documented clinical sustained ventricular tarbyeanfia both
in the absence and the presence of antiarrhylhmic drug
therapy: and 2) examine the reproducibility of specific
cachycardia characteristics such as mode of induction, cycle
length and surface electrocardiographic (ECG) patient .
Methods
Stud) patinas . A total of IOb electroph ariologic studies
were conducted in 53 Patients . There were 43 men and 10
women with a mean age of to ± 12 years. All patients
underwent cardiac catheterization and coronary angiogra-
phy . Coronary artery disease was present in 44 patients,
dilated congestive cardiomyopathy in 3 and other underlying
heart disease in 6 . Of the 44 patients with coronary artery
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disease, there were 19 patients with transmural anterior wall
infarction (II with left ventricular aneurysm), 15 with trans-
mural inferior wall infarction (2 with aneurysm), 9 with both
anterior and inferior infarction (I with an inferobasal aneu-
rysm) and I with no transmural infarction
. All patients had
wall motion abnormalities, and the mean left ventricular
ejection fraction was 31 ± 14% . The clinical presentation
was sustained monomorphic ventricular tachycardia docu-
mented in all 53 patients .
Study design
. One hundred six electrophysiologic studies
were prospectively carried out in 53 consecutive patients
who presented with spontaneous sustained monomorphic
ventricular tachycardia documented by a 12 lead FCC and
who met the following additional criteria : I I sustained muno •
morphic ventricular tachycardia was induced by pro-
grammed cardiac stimulation in the absence of antiarrhyth-
mic drug therapy in each patient ; and 2) the induced
ventricular tachycardia was terminated by ventricular pacing
and did not require cardioversion by direct current counter-
shock during that particular study . Patients in whom pro-
grammed cardiac stimulation resulted in ventricular fibrilla-
tion or ventricular tachycardia requiring direct current
couatershoek for termination were excluded from this study
to prevent repeated eardioversions for safety and humane
considerations and to avoid possible postcardloversien elec-
trophysiulugic alterations that might interfere with immedi-
ate reproducibility of tachycardia induction
. Patients with
ventricular nrrhythmias occurring in the setting of acute
myocardial infarction or metabulic abnormalities were also
excluded-
Patients who had stopped an antialThythmic drug for
more than five halt-lives, or for at least 3 months in those
previously taking amiodarone, were considered free of drug
and underwent a programmed cardiac stimulation protocol .
Similar studies were subsequently performed in the presence
of antiarrhythmic drugs in 33 of these 53 patients who went
on to have follow-up studies during antiarrhythmic drug
therapy
. A total of 53 drug trials were performed in 33
patients . The antiarrhythmic agent was procainamide during
16 trials, amiodarone during 14 trials, quinidine during 4
trials and disopyramide in 1 . The remaining 18 trials were
performed during treatment with a combination of drugs
(procainamide and tocainide in 6, procainamide and mexi-
letine in 2, quinidine and mexiletine in 7, quinidine and
tocainide in 2 and disopyramide and mexiletine in 1) . Serial
drug studies were not carried out in the remaining 20 patients
for various clinical reasons, but mostly because of decisions
in favor of nonpharmacologic methods of treatment . Eigh-
teen of the 33 patients had I follow-up study on an amiar-
rhythmic drug regimen, 10 patients had 2 studies on 2
different antiarrhythmiu drug regimens and 5 patients had 3
studies on 3 distinct regimens, with a total of 53 studies
during antiarhyrhmie drug therapy in 33 patients . With
amiodarone therapy, programmed cardiac stimulation was
performed after a period of 10 to 14
days of drug loading,
with doses ranging from 1,200 to 1,f00 mg/day .
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Programmed stimulation protocol . The elcetrophysio-
logic studies were carried out in compliance with the guide-
lines of the Human Studies Committee at our institution
.
Patients were studied in the pnstahsnrptive state after in-
formed consent had been obtained . Multipolar electrode
catheters were positioned under fluoroscopic guidance in the
high right atrium, right ventricular apex and across the
tricuspid valve anulus . During a serial drug study, a bipolar
electrode catheter was positioned at the same site as the site
of prior lochyeardia induction . Programmed electrical stim-
utation using up to three extrastimuli was performed with a
programmable stimulator (Medtronic model 5329) using rec-
tangular stimuli with a pulse width of 2 ms at five times
diastolic threshold, Catheter position was readjusted until
the diastolic threshold was <I mA before any programmed
cardiac stimulation . Diastolic threshold was defined at the
beginning of each study and redefined after the induction of
the first tachycardia before repeat programmed cardiac
stimulation .
Starling at the tight ventricular apex, one, two and three
extrastimuli were introduced at two drive cycle lengths (600
and 400 ms), with coupling intervals starting at an S,S2
interval of 2D ms + the effective refractory period and of
50 ms + the refractory period for 8,S, and S,S, and
decremented by 10 ms at a time until ventricular refractori-
ness was encountered for all extrastimuli
. The end point of
the stimulation protocol was induction of sustained ventric-
ular tachycardia or completion of the stimulation protocol,
including the use of a third extrastimulus (S 4 ) for all studies .
if sustained veulnealar tachycardia was not initiated from
the right ventricular apex, the same stimulation protocol was
repeated from the right ventricular outflow tract . Pro-
grammed left ventricular stimulation was not used in this
study.
Immediately antler the electrical induction of sustained
ntonomorphic ventricular tachycardia, a 12 lead ECG was
recorded in every case and ventricular pacing was tried to
terminate the tachycardia . If enrdioversion was not required,
reproducibility of tachycardia induction was tested in the
same setting by starting the identical stimulation protocol
from the same site of stimulation without any change in
catheter position after a rest period of approximately 10 min,
during which any symptoms that might be present were
allowed to resolve and vital signs allowed to return to
preinduction values . As with the first stimulation protocol,
the coupling intervals were decremented and the number of
extrastimuli in::reascd until either sustained ventricular
tachycardia was neinitinted or the protocol using a maximum
of three ventricular extrastimuli was completed .
Definitions. Sustained monomorphic ventricular tachy-
cardia was defined as ventricular tachycardia with no beat to
beat variation in rate and ECG configuration (QRS width and
mean frontal and horizontal axes) . lasting =_100 beats or
requiring pacing for termination. Nonsustained ventricular
tachycardia was defined as ventriculartachycardia manifest-
ing 03 and <100 beats, reverting to sinus rhythm sponinne-
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Table 1. Rate of Reproducibility of Ventricular Tachycardia i VTi
Induction and Incidence of Similarity in Reproduced Tachycardia
in the Drug-Free Stale and During Anliarrhythmic Drug
Therapy IAAD)
D=disopyramide; M= mesae6nr : P=
p,--d,
Q = glunidine :
In-
mcainide .
ously
. Sustained ventricular Lu :hycardia induction watt con-
sidered reproducible if after the induction of the first
sustained ventricular tachycardia- a second sustained ven-
tricular tachycardia could be reinitiated using a maximum of
three ventricular exlrastimuli from the same site of stimula-
tion, regardless of the number of extrastimuli required for
the first induction and regardless of the similarities or
differences in rate and surface ECG pattern between the two
sustained ventticulartachycardias .
The rates of the two induced venrricular tachycardias in
the same patient were considered similar if their cycle
lengths differed by less than 40 ins- The morphologic simi-
larity between different tachycardias was hosed nn ECG
criteria and not on activation sequence mopping . Two ven-
tricular tachycardias were considered similar in ECG con-
figuration if both their mean frontal and mean horizontal
ECG axes differed by less than 45°. criteria previously used
in our laboratory (12). Tachycardias manifesting both similar
rates and similar ECG configuration were classified as sim-
ilar. Otherwise they were considered to be different.
Statistical analysis . Fishers exact test and McNemars
test for paired sample numinai-scale data 1131 were used to
compare reproducibility of tachycardia induction among
different groups . The latter is a test of independence o r . i n
this case, a test of whether the patients who have reproduc-
ible results during one study but not the other are evenly
divided between the groups being compared . McNemars
test was also used to compare the proportions of similar and
different ventricular tachycardias among various groups,
Results
Overall reproducibility (TaUE 11 . In the 53
patients, sun .
rained monomorphic ventricular tachycardia was induced
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Tahk 2. Differences in Rate and Morphdogy Between the First
and Second Induced Ventricular Tochycardia In - hilt
5'.nvlar 'A' and rornl 65 16311
Ibttawa mo-halogy only 19111.11
MIT,- mlr
and mnrphotogy
1) 13411
Din'-1 rele
on
!y 7 ; 9 1,41
for the second time by programmed cardiac stimulation after
the first induction in 104 (981/%) of the 106 studies. The site of
stimulation for both the first and the second induction was
the right ventricular apex in 92 studies and the right ventric-
ular outflow tract in 12. In 2 (2%) of 106 studies . ventricular
tachycardia could not be reinitiated by programmed cardiac
stimulation . These two nonrepraducble induced ventricular
tachycardias were observed in two different patients who
underwent their studies in a drug-free state . Thus . using our
general definition of overall reproducibility far ventricular
tachycardia induction (see Methodsl, the overall reproducibil-
ity was 98% . In the remaining two studies, the initial tachycar-
din was initiated by three cxtrastimuh and could not he repro-
duced using three extraslemuli during the second attempt .
In 53 studies performed in 33 patients off entiarrhvthnic
drug therapy . sustained ventricular tachycardia induction was
reproducible in 5I (%%I (Table I)_ The overall reproducibility
of tachycardia induction for the 53 studies performed during
antiarhythmic drug therapy was I00`/c, regardless of the spe-
cific antiarhythmiC drug regimen used . Using either Fisher's
enact test on the whole samples tunmatched) or McMernar's
test for paired sample testing, there was no sigdficant di er-
ence in reproducibility of tachycardia induction among the
different categories listed in Table I .
Reproducibility of Ventricular Tachycurdia
Citcrrrrr teristic .s (Tables I and 2)
Kale and ECU configuration. The mean cycle length of all
induced ventricular tachycardias was 370 -- 85 ms (range 200
to 600)
.
The first and second induced ventricular tachycardia
analyzed in 104 studies of reproducible induction were
similar in both rate and ECG configuration in 65 studies
(Table I), resulting in a 63% incidence of similarity for
reproduced sustained monomorphic ventricular tachycardia .
For the remaining 39 studies 137%1, the first and the second
induced tachycardias were different because of a difference
in ECG configuration (18%) . rate (7%) or both (13%) (Table
21
. In the 20 studies in which the note of the first and second
ventricular tachycardia was different (Table 2), the mean
difference in cycle length was 103 ± 74 ms .
Hemodynamietolerance. This was a function of tachycar-
din cycle length : there was no difference in hemodynamic
tolerance between the first and second tachycardia when
similar tachycardias were induced. Ventricular pacing wan
uniformly successful in terminating ventricular tachycardia
after the second induction of ventricular tachycardia, as with
A0DTherapy
Overall
Reprodueibilila
.0T
Inauuian
Reproduced
VT
Similar
Reproduced
VT
Different
Na AAD 51,53 32'51 19;51
In
n 53) (96)4, (63)11
1371!
P Or Q or D 21,21
13, 21 S^-1
(a = 211 I100K] 1629ri 179911
Combination 1a99 13118 5 , 18
(PorQoaD+ IDOW)
1711
.1 289.1
Mar
TI
In = 191
Amiodarone 14114 7114 7/14
In = 141 11071 150154 1 W)
Total 100006 65)101 191104
In=Will 198%) 163%) (37%)
F36
	
KU5SNUAVM Is AL.
JACC Vat- I' . Na. I
RI :PRrtvECIaII TTY OF INDUCED VENTRICULAR TACIiYCAROIA k .."
1591 1 r3-8
Tabtr 3. Number of Fatrnaimuli i FS] Used in Initiate Ventricular Taehyeardia (VT) During the First and Second programmed Electrical
Sumldati on (PES)
VT Durine 2nd PES In = 1041
the first when a similar ventricular tachycardia was rein-
duced . C'ardioversion with cmmtershock was required to
terminate the second ventricular lachycardia in 10 studies
.
Effen of drug on rate and ECG configuration (Table 1)
.
The incidence of similar and different ventricular tachycar
•
Bias during the first and second induction in the same patient
was separately determined for the drug-free state and dif-
ferent modes of antiarrhythmic drug therapy The incidence
of similar ventricular lachycardias was 63% in the drug-free
group and nearly identical (627a) for all studies coadacted on
antiarrhythmic drug therapy . The incidence of similar tachy-
cardias was highest (72%) during therapy with the combina-
tion of a class iA and class IR agent and lowest (50501 with
amiodarone . However
. there were no significant differences
in the proportion of similar ventricular lachycardias among
the groups compared either by Fisher's exact or McNemar' s
paired sample test .
The 33 patients in whom both a drug-free baseline study
and subsequent studies on antiarhythmic drugs were con-
dueled were analyzed separately . The incidence of similar
tachycardias during reproducible baseline inductions was
64% compared with 60% for nil studies performed on drugs
in these 33 patients. Comparison of drug-free baseline stud-
ies with studies on specific drugs resulted in the following
incidence rates of similar ventricular tachycardia in individ-
ual patients . 62% and 62% for baseline versus class IA ; 58%
versus 509E for baseline versus amiodarone and 67% versus
72% for baseline versus class [A and class It8 combination
.
Location of scar or aneurysm. In 44 patients with coro-
nary artery disease, the location of scar and the presence of
left ventricular aneurysm did not appear to affect the
inci-
dence of similar or different ventricular tadtycardias during
socccssivc inductions. The incidence of similar lachycardias
was 58% in patients
with anterior infarction, 6(1% in patients
with inferior infarction, 56% in patients with both anterior
and inferior infarction and 66% in patients without ischemic
heart disease . The incidence of similar lachycardias wits 57%
in 14 patients with left ventricular aneurysm and 60% •
in 30
patients with ischemic heart disease hut without a left
ventricular aneurysm .
Reproducibility of Induction Characteristics
(Table 3)
Number of extrastil" . In 95 (91%1 of the 104 studies
with reproducible induction, sustained ventricular tachycar
dia was reinitiated using the same number of extrastimuli
and in the remaining 9
(9%), an additional extrastimulus was
regnired
. Sustained ventricular tachycardia was initially
induced whit a single extrastimulus in 33 studies, and in
27 (82%) of these, the second induction of ventricular
lachycardia was also initiated with a single extrastimulus .
Sustained ventricular tachycardia was initiated with double
extrastimuli in 50 studies, and in 47 (04901 of these, tachy-
cardia could be reinitiated by two extrastimuli . Thus, to
reproduce sustained ventricular tachycardio, an increase in
the number of extrastimuli was required in 9 (11%) of 83
studies in which one or two extrastimuli were initially
required to induce the tachycardia . In the two studies where
three extrastimuli induced the first but not the second
tachycardia, more than three extrastimuli were not used to
test the reproducibility during the second induction attempt
because stimulation through three extrastimuli was an end
point for our protocol
.
Number of extrastlmuli versus shullarlty, of induced tochy-
cardia
.
.The effect of the cumber of extrastimuli on the
similarity and difference between the twice-induced ventric-
ular tachycardias was assessed in those studies in which the
number of extrastimuli for the first and the second induction
was the same, Similar ventricular lachycardias were initiated
in 63% of studies using a single extrastimulus for both
inductions, in 06% of studies using double extrastimuli for
both inductions and in S7% of studies using triple extrastim-
uli for both inductions . These differences were not statisti-
cally significant .
Discussion
Reproducibility of induced sustained ventricular tachycar
•
dia . Management of recurrent sustained ventricular tachy-
cardia frequently involves antiarrhythmic drug therapy
VT
Initialed
wah
1 PES
la=2'I
2 P:.S
to
= 531
3 PES
In = 291
Overall
xnPOJ VISjrty
Reindaced by
Same No, of
PES as F-
I I'CS 27 4 33133
27173
In - 337 (1o") (8214)
Vi durim Icl PFS 2 PFS 41, 3 90156 47950
In= 1091 In = so) IIW%1
(94)91
J PES
21 2123 21123
[n = 19170
191%1
Ton : 1641[66 951104
In - lob)
(989tt
191%)
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guided by eleetrophysiologic testing- Reports from this (4)
and other (4,5) laboratories have shown that suppression of
arrhythmia induction by acute intravenous drug administra-
tion predicts, with varying degrees of success, subsequent
tachycafdia suppression by the same or other antiarrhythmic
drugs . The prognostic significance of the response to pro-
grammed cardiac stimulation and assessment of antiarrhyth-
mic efficacy require that the results are reproducible . This
prospective study demonstrates that in a selected subgroup
of patients presenting with documented sustained ventricu-
lar arrhythmias, the immediate reproducibility of sustained
ventricular tachycardia induction by programmed catdiac
stimulation is very high in the drug-free state and during
antiarrhythmic drag therapy
. Furthermore, the mode of
stimulation required to induce sustained ventricular tachy-
cardia does not change from the first to the second induction
in the vast majority of cases (91%) .
Studies in the absence of antiarrhythmic drug therapy .
Previous studies (14-16) addressing day to day rather than
immediate reproducibility reported changes in induction
mode in up to 32% of the cases, but some of these studies
also included nonsustained ventricular tachycardia as an end
point. Two other studies (10,11) more comparable with ours,
addressing the immediate reproducibility of the response to
programmed cardiac stimulation, reported similar high over .
all reproducibility rates . De Buitleir et al . (10) found 91%
immediate reproducibility during a second induction trial of
what they regarded as clinical ventricular mchycardia . In a
recent study using a unique protocol with up to five extra-
stimuli in a smaller group or patients. Cooper et at
. (I I)
showed 100% sensitivity and immediate reproducibility of
Inchycardia induction . However if their results using only up
to three extrastimuli are considered. their reproducibility of
induction becomes very similar to ours . These investigators
further demonstrated that 94% of the tachycardias requiring
two extrastimuli for initiation during the first induction could
be reproduced with the use of two extrastimuli during the
subsequent trial, same as our 94e/ (Table 3) despite the
differences in protocol between the studies .
The overall reproducibility of induction mode or the
number of extrastimuli required for tachycardia initiation,
was higher in our study (89%) compared with the previously
reported value of 81% by De Buitleir et al . (I0) and 74%
by Cooper et al . (11) if only their first two of three induc-
tions are considered . Differences in patient groups and the
stimulation protocols used may account for these differ-
ences among the studies in reproducibility of induction
mode .
Changes in rate and ECG morphology . Although repro-
ducibility of ventricular tachycardia induction is tested in
many laboratories, analysis of QRS configuration during
ventricular tachycardia ha, frequently been limited to a
few
surface ECG leads . precluding careful assessment of
changes in frontal and horizontal axes . The present study
bases the similarities in configuration between separate
tachycardia episodes on characteristics of the 12 lead ECG
1 3 7
in all studies . This approach, previously used in our lahora-
tury (12), was not intended to describe similarity in site of
origin or activation sequence . but to compare the ventricular
tachycardia pattern by using an easily accessible clinical
tool, the 12 lead ECG, without any implication regarding the
underlying mechanisms .
In our study, the reproducibility of the characteristics of
the induced ventricular tachycardia was substantially lower
(63%t than the reproducibility of induction (98%) . The most
common difference between the two successively induced
tachycardias, occurring in 18% of studies, was a difference in
ECG configuration with a similar cycle length . We cannot
comment on the mechanism underlying this phenomenon
because detailed mapping data were not available for any of
the studies . Using a definition of similarity between ventric-
ular lachycardias similar to the definition used in our study,
Cooper et al, (1l) found a 36% incidence of different tachy-
cardia configuration during immediate reproducibility test-
ing, almost identical to the 37% incidence of dissimilar
ventricular lachycardias observed in our study .
Limitations . This prospective study was carried out in a
selected group of patients who presented with documented
sustained monomorphic ventricular tachycardia- Our results
should not be generalized to patients presenting with out of
hospital cardiac arrest, nonsustained ventricular tachycardia
or syncope because they may manifest different types of
induced arrhythmias and induction characteristics than the
homogeneous group we describe in this study .
Although the reproducibility of sustained ventricular
tachycardia was extensively evaluated in this s tudy . i
t
was
not tested in patients requiring cardioversion for several
reasons . In addition to the safely and humane consider-
ations. we could not lode out the possibility that direct
current countershock may reversibly alter myocardium long
enough to interfere with immediate reproducibility testing .
Regardless of the reasons, however. as a result of our policy .
we could not assess the reproducibility of induction for
lachycardias with relatively rapid rates (average tachycardia
rate in our study 165 beatslmin), which frequently required
cardiovcrsioa, or of ventricular tachycardias. which regard-
less of the rate, were refractory to termination by ventricular
pacing . Reproducibility of ventricular lachycardias with
relatively short cycle lengths remains an unresolved but
clinically important topic that needs further investigation,
especially because hemedynamic collapse is more likely to
occur with rapid tachycardias .
In our study, the two tachycardias that could not be
induced a second time manifested rates comparable with the
average rate . However, because these lachycardias repre-
sented an extremely small subgroup precluding any statisti-
cal analysis, it is not known with certainty whether the rate
or induced ventricular tachycardia is a factor that correlates
with reproducibility of induction . If so, the overall reproduc-
ibility of all induced ventricular tachycardas . including the
very rapid ones requiring curdioversion, may differ from the
values reported in this study .
1 3 8
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Clinical implications. The high incidence of
immediate
reproducibility of tachycardia induction in this highly se-
lected group of
patients provides a rational basis and accept-
able confidence limits for acute intravenous antiarrhyth-
mic drug testing in the electrophysiology laboratory in
similar groups of patients
. Our study shows that persistence
of induced tachycardia during antiarrhythmic drug therapy
or failure to suppress the induced tachycardia is also a
highly reproducible phenomenon . lending further support
to the rationale behind acute drug testing in similar pa-
tents.
In the absence
of
complete suppression of induced ven-
tricular tachycardia, management may he influenced by
factors such as modulations in the rate of the induced
laehycardias and changes in the number of
exlrastimuli
required to induce them (7-9) . Naccarclli et al . (8) found a
higher recurrence rate when ventricular Inchyeardia was
initiated with fewer exlrastimuli in patients on amiodarone .
Breithardt el al, (7) demonstrated a significant I year reduc-
tion in recurrent ventricular tachycardia or sudden death
when tachycardia was either completely suppressed or more
diffteLlt to induce. Furthermore, changes in induced Ventric-
ular tachycardia cycle length are sometimes used as a
marker of antiarrhythmic and pruarrhythmic drug effects
.
Waller
ci
al . (9) suggested that drug-associated slowing of
the induced ventricular tachycardia rate predicted a low
incidence of sudden death during long-term antiarrhythmic
drug therapy
. Such changes, however, should be inrerpreted
with caution because in 20% of our studies, induced tachy-
cardia rates were substantially different
(>40
ms change
in cycle length) between the first and the second induc-
tion, even without alterations in drug therapy . These data
on reproducibility of cycle length during the same study
should he taken into consideration when making clinical
decisions .
Conclusions . The overall immediate reproducibility of
induction of sustained monomorphic ventricular tachycardia
in patients presenting clinically with this arrhythmia is
extremely high, although in a minority of patients . an in-
crease in the number of extrastimuli is required to reinitiate
the tachycardia . This finding supports the reliability of
ventricular tachycardia induction as a marker against which
future therapeutic interventions may be assessed . However,
significant differences in specific surface ECG configuration
or cycle length occur in 37% of the studies, even in . .
.s
setting These latter observations suggest that caution must
be used in attributing clinical or prognostic significance to
changes in induced tachycardia cycle length or
ECU
pattern
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after therapeutic interventions- particularly if baseline vari-
ability has not been defined .
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